Marilena Hadjidemetriou

Statistics

Publications

Citations

1.9K

H-Index

Active since

2013

Affiliations

University of Manchester(Current)

Manchester Academic Health Science Centre

Henry Royce Institute

Institut Català de Nanociència i Nanotecnologia

Cancer Research UK Manchester Institute

Marilena Hadjidemetriou is an author at University of Manchester specializing in nanomedicine, biochemistry, and biomolecule-nanoparticle interactions.

ORCID

Publications per year

2013–2025

Publications

<i>In vivo</i> formation of protein corona on gold nanoparticles. The effect of their size and shape

Rafaela García-Álvarez, Marilena Hadjidemetriou, Ana Sánchez‐Iglesias et al. · Nanoscale · 2017 · 365 citations · Full text

Pharmacy, Biochemistry, Biomedical Sciences +17

<i>In Vivo</i> Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles

Marilena Hadjidemetriou, Zahraa S. Al-Ahmady, Mariarosa Mazza et al. · ACS Nano · 2015 · 336 citations

Pharmacy, Biochemistry, Pharmaceutics +17

Evolution of the nanoparticle corona

Marilena Hadjidemetriou, Kostas Kostarelos · Nature Nanotechnology · 2017 · 324 citations

Natural Sciences, Chemistry, Materials Science +12

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles

Marilena Hadjidemetriou, Zahraa S. Al-Ahmady, Kostas Kostarelos · Nanoscale · 2016 · 207 citations · Full text

Pharmacy, Biochemistry, Pharmacology +17

The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof‐of‐Concept Clinical Study

Marilena Hadjidemetriou, Sarah McAdam, Grace Garner et al. · Advanced Materials · 2018 · 173 citations

Pharmacy, Biochemistry, Oncology +17

1–5 of 17